Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings

被引：0
|
作者：
Naomi M. Simon
Kathryn M. Connor
Richard T. LeBeau
Elizabeth A. Hoge
John J. Worthington
Wei Zhang
Jonathan R. T. Davidson
Mark H. Pollack
机构：
[1] Massachusetts General Hospital and Harvard Medical School,
[2] Duke University,undefined
[3] Merck Research Laboratories,undefined
[4] Merck & Co,undefined
[5] Inc.,undefined
[6] Massachusetts General Hospital,undefined
来源：
Psychopharmacology | 2008年 / 197卷
关键词：
GAD; Refractory; Paroxetine; Quetiapine; Augmentation; Anxiety; Pharmacotherapy; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：675 / 681
页数：6
相关论文
共 50 条
  • [21] Paroxetine treatment of generalized social phobia (social anxiety disorder) - A randomized controlled trial
    Stein, MB
    Liebowitz, MR
    Lydiard, RB
    Pitts, CD
    Bushnell, W
    Gergel, I
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (08): : 708 - 713
  • [22] Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder
    Allgulander, C
    Cloninger, CR
    Przybeck, TR
    Brandt, L
    PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (02) : 165 - 166
  • [23] Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder
    Kim, Tae-Suk
    Pae, Chi-Un
    Yoon, Su-Jung
    Bahk, Won-Myong
    Jun, Tae-Youn
    Rhee, Won-Ihl
    Chae, Jeong-Ho
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (03) : 347 - 351
  • [24] Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder
    D'Amico, G
    Cedro, C
    Muscatello, MR
    Pandolfo, G
    Di Rosa, AE
    Zoccali, R
    La Torre, D
    D'Arrigo, C
    Spina, E
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04): : 619 - 623
  • [25] A pharmacoeconomic evaluation of escitalopram vs. paroxetine in the treatment of generalized anxiety disorder in Norway
    Danchenko, N.
    Maehlum, E.
    Hansen, K.
    Despiegel, N.
    Holsten, F.
    VALUE IN HEALTH, 2007, 10 (06) : A296 - A296
  • [26] Preliminary indications of the efficacy of EMDR in the treatment of generalized anxiety disorder
    Gauvreau, Philippe
    Bouchard, Stephane
    JOURNAL OF EMDR PRACTICE AND RESEARCH, 2010, 4 (04): : E47 - E62
  • [27] Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study
    Yi-Chih Chen
    Chih-Ken Chen
    Liang-Jen Wang
    BMC Psychiatry, 12
  • [28] Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study
    Chen, Yi-Chih
    Chen, Chih-Ken
    Wang, Liang-Jen
    BMC PSYCHIATRY, 2012, 12
  • [29] Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study
    Rickels, K
    Zaninelli, R
    McCafferty, J
    Bellew, K
    Iyengar, M
    Sheehan, D
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 749 - 756
  • [30] Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?
    Carey, Paul D.
    Lochner, Christine
    Kidd, Martin
    Van Ameringen, Michael
    Stein, Dan J.
    Denys, Damiaan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (06) : 321 - 325
12345